Serveur d'exploration H2N2

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Le cluster Vaccins antigrippaux (immunologie) - Vaccins atténués (immunologie)

Terms

121Vaccins antigrippaux (immunologie)
55Vaccins atténués (immunologie)
62Vaccins antigrippaux (administration et posologie)
118Femelle
64Mâle
73Souris de lignée BALB C
69Sous-type H2N2 du virus de la grippe A (immunologie)
62Basse température

Associations

Freq.WeightAssociation
5050Vaccins antigrippaux (immunologie) - Vaccins atténués (immunologie)
4848Vaccins antigrippaux (administration et posologie) - Vaccins antigrippaux (immunologie)
4747Femelle - Vaccins antigrippaux (immunologie)
4747Femelle - Mâle
4242Femelle - Souris de lignée BALB C
3535Sous-type H2N2 du virus de la grippe A (immunologie) - Vaccins antigrippaux (immunologie)
3333Femelle - Sous-type H2N2 du virus de la grippe A (immunologie)
3131Basse température - Vaccins antigrippaux (immunologie)
3030Souris de lignée BALB C - Vaccins antigrippaux (immunologie)
2828Femelle - Vaccins antigrippaux (administration et posologie)
2424Sous-type H2N2 du virus de la grippe A (immunologie) - Vaccins antigrippaux (administration et posologie)
2222Femelle - Vaccins atténués (immunologie)
2020Basse température - Vaccins atténués (immunologie)
1919Vaccins antigrippaux (administration et posologie) - Vaccins atténués (immunologie)
1818Mâle - Vaccins antigrippaux (immunologie)
1616Souris de lignée BALB C - Vaccins antigrippaux (administration et posologie)
1616Souris de lignée BALB C - Sous-type H2N2 du virus de la grippe A (immunologie)
1616Mâle - Sous-type H2N2 du virus de la grippe A (immunologie)
1414Sous-type H2N2 du virus de la grippe A (immunologie) - Vaccins atténués (immunologie)
1414Souris de lignée BALB C - Vaccins atténués (immunologie)
1313Mâle - Vaccins antigrippaux (administration et posologie)
1313Mâle - Souris de lignée BALB C
1212Basse température - Femelle
1111Basse température - Vaccins antigrippaux (administration et posologie)
1111Basse température - Sous-type H2N2 du virus de la grippe A (immunologie)
1111Basse température - Souris de lignée BALB C

Documents par ordre de pertinence
001496 (2006) Kwang-Hee Lee [Corée du Sud] ; Sang-Uk Seo ; Jae-Min Song ; Chung-Min Lee ; Hyun-Ah Kim ; Baik L. SeongCharacterization of live influenza vaccine donor strain derived from cold-adaptation of X-31 virus.
002D95 (????) A R Rekstin ; K. Lu ; D. Kats ; L G Rudenko[Production of early cytokines after infection with A/Leningrad/134/57 (H2N2) wide-type virus and cold-adapted attenuated vaccine viruses].
000741 (2014) Irina Isakova-Sivak [États-Unis, Russie] ; Li-Mei Chen [États-Unis] ; Melissa Bourgeois [États-Unis] ; Yumiko Matsuoka [États-Unis] ; J. Theo M. Voeten [Pays-Bas] ; Jacco G. M. Heldens [Pays-Bas] ; Han Van Den Bosch [Pays-Bas] ; Alexander Klimov [États-Unis] ; Larisa Rudenko [Russie] ; Nancy J. Cox [États-Unis] ; Ruben O. Donis [États-Unis]Characterization of Reverse Genetics-Derived Cold-Adapted Master Donor Virus A/Leningrad/134/17/57 (H2N2) and Reassortants with H5N1 Surface Genes in a Mouse Model
000A85 (2012) Kawsar R. Talaat ; Ruth A. Karron ; Philana H. Liang ; Bridget A. Mcmahon ; Catherine J. Luke ; Bhagvanji Thumar ; Grace L. Chen ; Ji-Young Min ; Elaine W. Lamirande ; Hong Jin ; Kathy L. Coelingh ; George W. Kemble ; Kanta SubbaraoAn open‐label phase I trial of a live attenuated H2N2 influenza virus vaccine in healthy adults
000E67 (2010) Chih-Jen Wei [États-Unis] ; Jeffrey C. Boyington ; Patrick M. Mctamney ; Wing-Pui Kong ; Melissa B. Pearce ; Ling Xu ; Hanne Andersen ; Srinivas Rao ; Terrence M. Tumpey ; Zhi-Yong Yang ; Gary J. NabelInduction of broadly neutralizing H1N1 influenza antibodies by vaccination.
000F07 (2010) Ji-Young Min [États-Unis] ; Leatrice Vogel ; Yumiko Matsuoka ; Bin Lu ; David Swayne ; Hong Jin ; George Kemble ; Kanta SubbaraoA live attenuated H7N7 candidate vaccine virus induces neutralizing antibody that confers protection from challenge in mice, ferrets, and monkeys.
001044 (2009) Grace L. Chen [États-Unis] ; Elaine W. Lamirande [États-Unis] ; Hong Jin [États-Unis] ; George Kemble [États-Unis] ; Kanta Subbarao [États-Unis]Safety, Immunogencity and Efficacy of a Cold-Adapted A/Ann Arbor/6/60 (H2N2) Vaccine in Mice and Ferrets
001283 (2008) Tomy Joseph [États-Unis] ; Josephine Mcauliffe ; Bin Lu ; Leatrice Vogel ; David Swayne ; Hong Jin ; George Kemble ; Kanta SubbaraoA live attenuated cold-adapted influenza A H7N3 virus vaccine provides protection against homologous and heterologous H7 viruses in mice and ferrets.
002E38 (????) O S Kashirina ; M I Chernikova ; Yu M. Vasiliev[COMPARATIVE STUDY OF IMMUNOGENICITY AND PROTECTIVE EFFECT OF LIVE COLD-ADAPTED AND INACTIVATED VACCINES AGAINST TYPE A INFLUENZA].
000563 (2015) Irina Kiseleva [Russie] ; Irina Dubrovina [Russie] ; Ekaterina Fedorova [Russie] ; Natalie Larionova [Russie] ; Irina Isakova-Sivak [Russie] ; Ekaterina Bazhenova [Russie] ; Maria Pisareva [Russie] ; Victoria Kuznetsova [Russie] ; Jorge Flores [États-Unis] ; Larisa Rudenko [Russie]Genetic stability of live attenuated vaccines against potentially pandemic influenza viruses.
000602 (2015) Mariana Baz [États-Unis] ; Myeisha Paskel [États-Unis] ; Yumiko Matsuoka [États-Unis] ; James R. Zengel [États-Unis] ; Xing Cheng [États-Unis] ; John J. Treanor [États-Unis] ; Hong Jin [États-Unis] ; Kanta Subbarao [Indonésie]A Single Dose of an Avian H3N8 Influenza Virus Vaccine Is Highly Immunogenic and Efficacious against a Recently Emerged Seal Influenza Virus in Mice and Ferrets.
000A23 (2012) Jianzhong Shi [République populaire de Chine] ; Zhiyuan Wen ; Jing Guo ; Ying Zhang ; Guohua Deng ; Yuelong Shu ; Dayan Wang ; Yongping Jiang ; Yoshihiro Kawaoka [États-Unis] ; Zhigao Bu ; Hualan ChenProtective efficacy of an H1N1 cold-adapted live vaccine against the 2009 pandemic H1N1, seasonal H1N1, and H5N1 influenza viruses in mice.
000A27 (2012) Filippo Ansaldi [Italie] ; Laura Valle ; Daniela De Florentiis ; Valentina Parodi ; Giuseppe Murdaca ; Bianca Bruzzone ; Paolo Durando ; Maurizio Setti ; Giancarlo IcardiPhase 4 randomized trial of intradermal low-antigen-content inactivated influenza vaccine versus standard-dose intramuscular vaccine in HIV-1-infected adults.
000C34 (2011) Yanwei Zhong [République populaire de Chine] ; Jiong Cai [République populaire de Chine] ; Chuanfu Zhang [République populaire de Chine] ; Xiaoyan Xing [République populaire de Chine] ; Enqiang Qin [République populaire de Chine] ; Jing He [République populaire de Chine] ; Panyong Mao [République populaire de Chine] ; Jun Cheng [République populaire de Chine] ; Kun Liu [République populaire de Chine] ; Dongping Xu [République populaire de Chine] ; Hongbin Song [République populaire de Chine]Mimotopes selected with neutralizing antibodies against multiple subtypes of influenza A
000C50 (2011) Penghui Yang [République populaire de Chine] ; Yueqiang Duan ; Cheng Wang ; Li Xing ; Xiao Gao ; Chong Tang ; Deyan Luo ; Zhongpeng Zhao ; Weihong Jia ; Daxin Peng ; Xiufan Liu ; Xiliang WangImmunogenicity and protective efficacy of a live attenuated vaccine against the 2009 pandemic A H1N1 in mice and ferrets.
000C86 (2011) Chao Qiu ; Yang Huang [République populaire de Chine] ; Qian Wang [République populaire de Chine] ; Di Tian ; Wanju Zhang ; Yunwen Hu ; Zhenghong Yuan ; Xiaoyan Zhang ; Jianqing XuBoosting Heterosubtypic Neutralization Antibodies in Recipients of 2009 Pandemic H1N1 Influenza Vaccine
000E85 (2010) Pierre Van Damme [Belgique] ; Robert Arnou ; Froukje Kafeja ; Anne Fiquet ; Patrick Richard ; Stéphane Thomas ; Gilles Meghlaoui ; Sandrine Isabelle Samson ; Emilio LedesmaEvaluation of non-inferiority of intradermal versus adjuvanted seasonal influenza vaccine using two serological techniques: a randomised comparative study.
000F44 (2010) J. Theo M. Voeten [Pays-Bas] ; Irina V. Kiseleva [Pays-Bas, Russie] ; Harrie L. Glansbeek [Pays-Bas] ; Stephanie M. C. Basten [Pays-Bas] ; Sandra K. M. Drieszen-Van Der Cruijsen [Pays-Bas] ; Larisa G. Rudenko [Russie] ; Han Van Den Bosch [Pays-Bas] ; Jacco G. M. Heldens [Pays-Bas]Master donor viruses A/Leningrad/134/17/57 (H2N2) and B/USSR/60/69 and derived reassortants used in live attenuated influenza vaccine (LAIV) do not display neurovirulent properties in a mouse model
001030 (2009) Amorsolo L. Suguitan ; Michael P. Marino ; Purvi D. Desai ; Li-Mei Chen ; Yumiko Matsuoka ; Ruben O. Donis ; Hong Jin ; David E. Swayne ; George Kemble ; Kanta SubbaraoThe influence of the multi-basic cleavage site of the H5 hemagglutinin on the attenuation, immunogenicity and efficacy of a live attenuated influenza A H5N1 cold-adapted vaccine virus
001132 (2009) Kawsar R. Talaat [États-Unis] ; Ruth A. Karron ; Karen A. Callahan ; Catherine J. Luke ; Susan C. Dilorenzo ; Grace L. Chen ; Elaine W. Lamirande ; Hong Jin ; Kathy L. Coelingh ; Brian R. Murphy ; George Kemble ; Kanta SubbaraoA live attenuated H7N3 influenza virus vaccine is well tolerated and immunogenic in a Phase I trial in healthy adults.
001737 (2003) H. Chen [États-Unis] ; Y. Matsuoka [États-Unis] ; David Swayne [États-Unis] ; Q. Chen [États-Unis] ; N. J. Cox [États-Unis] ; B. R. Murphy [États-Unis] ; K. Subbarao [États-Unis]Generation and characterization of a cold-adapted influenza A H9N2 reassortant as a live pandemic influenza virus vaccine candidate
001872 (2001) M. D. Wareing [Australie] ; J. M. Watson [Australie] ; M. J. Brooks [Australie] ; G. A. Tannock [Australie]Immunogenic and isotype‐specific responses to russian and US cold‐adapted influenza a vaccine donor strains A/Leningrad/134/17/57, A/Leningrad/134/47/57, and A/Ann Arbor/6/60 (H2N2) in mice
002D79 (????) Iu A. Desheva ; Kh Lu ; A R Rekstin ; D M Kats ; L G Rudenko ; A I Klimov[The inoculative properties of cold-adapted reassortant A(H5N2) influenza strain during intranasal administration to mice].
000160 (2018) Daniil A. Korenkov [Russie] ; Karen L. Laurie [Australie] ; Patrick C. Reading [Australie] ; Louise A. Carolan [Australie] ; Kok Fei Chan [Australie] ; Irina I. Isakova-Sivak [Russie] ; Tatiana A. Smolonogina [Russie] ; Kanta Subbarao [Australie] ; Ian G. Barr [Australie] ; Julie Villanueva [États-Unis] ; Svetlana Shcherbik [États-Unis] ; Tatiana Bousse [États-Unis] ; Larisa G. Rudenko [Russie]Safety, immunogenicity and protection of A(H3N2) live attenuated influenza vaccines containing wild-type nucleoprotein in a ferret model.
000176 (2018) Svetlana Shcherbik [États-Unis] ; Paul Carney [États-Unis] ; Nicholas Pearce [États-Unis] ; James Stevens [États-Unis] ; Vivien G. Dugan [États-Unis] ; David E. Wentworth [États-Unis] ; Tatiana Bousse [États-Unis]Monoclonal antibody against N2 neuraminidase of cold adapted A/Leningrad/134/17/57 (H2N2) enables efficient generation of live attenuated influenza vaccines
000318 (2017) Brian J. Lenny [États-Unis] ; Stephanie Sonnberg [États-Unis] ; Angela F. Danner [États-Unis] ; Kimberly Friedman [États-Unis] ; Richard J. Webby [États-Unis] ; Robert G. Webster [États-Unis] ; Jeremy C. Jones [États-Unis]Evaluation of Multivalent H2 Influenza Pandemic Vaccines in Mice
000449 (2016) J Rgen De Jonge [Pays-Bas] ; Irina Isakova-Sivak [Russie] ; Harry Van Dijken [Pays-Bas] ; Sanne Spijkers [Pays-Bas] ; Justin Mouthaan [Pays-Bas] ; Rineke De Jong [Pays-Bas] ; Tatiana Smolonogina [Russie] ; Paul Roholl [Pays-Bas] ; Larisa Rudenko [Russie]H7N9 Live Attenuated Influenza Vaccine Is Highly Immunogenic, Prevents Virus Replication, and Protects Against Severe Bronchopneumonia in Ferrets.
000550 (2015) José Vicente Pérez-Gir N ; Sergio G Mez-Medina ; Anja Lüdtke ; Cesar Munoz-Fontela [Allemagne]Intranasal Administration of Recombinant Influenza Vaccines in Chimeric Mouse Models to Study Mucosal Immunity.
000561 (2015) Irina Isakova-Sivak [Russie] ; Marina Stukova [Russie] ; Mariana Erofeeva [Russie] ; Anatoly Naykhin [Russie] ; Svetlana Donina [Russie] ; Galina Petukhova [Russie] ; Victoria Kuznetsova [Russie] ; Irina Kiseleva [Russie] ; Tatiana Smolonogina [Russie] ; Irina Dubrovina [Russie] ; Maria Pisareva [Russie] ; Alexandra Nikiforova [Russie] ; Maureen Power [États-Unis] ; Jorge Flores [États-Unis] ; Larisa Rudenko [Russie]H2N2 live attenuated influenza vaccine is safe and immunogenic for healthy adult volunteers
000577 (2015) Liudmila M. Tsybalova [Russie] ; Liudmila A. Stepanova [Russie] ; Victor V. Kuprianov [Russie] ; Elena A. Blokhina [Russie] ; Marina V. Potapchuk [Russie] ; Alexander V. Korotkov [Russie] ; Andrey N. Gorshkov [Russie] ; Marina A. Kasyanenko [Russie] ; Nikolai V. Ravin [Russie] ; Oleg I. Kiselev [Russie]Development of a candidate influenza vaccine based on virus-like particles displaying influenza M2e peptide into the immunodominant region of hepatitis B core antigen: Broad protective efficacy of particles carrying four copies of M2e.
000600 (2015) Mariana Baz [États-Unis] ; Myeisha Paskel [États-Unis] ; Yumiko Matsuoka [États-Unis] ; James Zengel [États-Unis] ; Xing Cheng [États-Unis] ; John J. Treanor [États-Unis] ; Hong Jin [États-Unis] ; Kanta Subbarao [Indonésie]A live attenuated equine H3N8 influenza vaccine is highly immunogenic and efficacious in mice and ferrets.
000691 (2014) Gerald Aichinger [Autriche] ; Barbara Grohmann-Izay [Autriche] ; Maikel V. W. Van Der Velden [Autriche] ; Sandor Fritsch [Autriche] ; Manuela Koska [Autriche] ; Daniel Portsmouth [Autriche] ; Mary Kate Hart [États-Unis] ; Wael El-Amin [États-Unis] ; Otfried Kistner [Autriche] ; P. Noel Barrett [Autriche]Phase I/II Randomized Double-Blind Study of the Safety and Immunogenicity of a Nonadjuvanted Vero Cell Culture-Derived Whole-Virus H9N2 Influenza Vaccine in Healthy Adults
000724 (2014) Grace L. Chen [États-Unis] ; Elaine W. Lamirande [États-Unis] ; Xing Cheng [États-Unis] ; Fernando Torres-Velez [États-Unis] ; Marlene Orandle [États-Unis] ; Hong Jin [États-Unis] ; George Kemble [États-Unis] ; Kanta Subbarao [États-Unis]Evaluation of Three Live Attenuated H2 Pandemic Influenza Vaccine Candidates in Mice and Ferrets
000730 (2014) Irina Isakova-Sivak [Russie] ; J Rgen De Jonge [Pays-Bas] ; Tatiana Smolonogina [Russie] ; Andrey Rekstin [Russie] ; Geert Van Amerongen [Pays-Bas] ; Harry Van Dijken [Pays-Bas] ; Justin Mouthaan [Pays-Bas] ; Paul Roholl [Pays-Bas] ; Victoria Kuznetsova [Russie] ; Elena Doroshenko [Russie] ; Vadim Tsvetnitsky [États-Unis] ; Larisa Rudenko [Russie]Development and Pre-Clinical Evaluation of Two LAIV Strains against Potentially Pandemic H2N2 Influenza Virus
000C35 (2011) T V Chirkova [Russie] ; A N Naykhin ; G D Petukhova ; D A Korenkov ; S A Donina ; A N Mironov ; L G RudenkoMemory T-cell immune response in healthy young adults vaccinated with live attenuated influenza A (H5N2) vaccine.
000F05 (2010) Alicia Sol Rzano [États-Unis] ; Jianqiang Ye [États-Unis] ; Daniel R. Pérez [États-Unis]Alternative Live-Attenuated Influenza Vaccines Based on Modifications in the Polymerase Genes Protect against Epidemic and Pandemic Flu▿
001087 (2009) Shufang Fan [République populaire de Chine] ; Yuwei Gao ; Kyoko Shinya ; Chris Kafai Li ; Yanbing Li ; Jianzhong Shi ; Yongping Jiang ; Yongbing Suo ; Tiegang Tong ; Gongxun Zhong ; Jiasheng Song ; Ying Zhang ; Guobin Tian ; Yuntao Guan ; Xiao-Ning Xu ; Zhigao Bu ; Yoshihiro Kawaoka [États-Unis] ; Hualan ChenImmunogenicity and protective efficacy of a live attenuated H5N1 vaccine in nonhuman primates.
001230 (2008) Jodi Mcgill [États-Unis] ; Nico Van Rooijen ; Kevin L. LeggeProtective influenza-specific CD8 T cell responses require interactions with dendritic cells in the lungs.
001252 (2008) Joo Sub Lee [Corée du Sud] ; Hyun Soo Kim ; Sang Heui SeoGenetic characterization and protective immunity of cold-adapted attenuated avian H9N2 influenza vaccine.
001476 (2006) Amorsolo L. Suguitan [États-Unis] ; Josephine Mcauliffe [États-Unis] ; Kimberly L. Mills [États-Unis] ; Hong Jin [États-Unis] ; Greg Duke [États-Unis] ; Bin Lu [États-Unis] ; Catherine J. Luke [États-Unis] ; Brian Murphy [États-Unis] ; David E. Swayne [États-Unis] ; George Kemble [États-Unis] ; Kanta Subbarao [États-Unis]Live, Attenuated Influenza A H5N1 Candidate Vaccines Provide Broad Cross-Protection in Mice and Ferrets
001492 (2006) Monika Lindemann [Allemagne] ; Oliver Witzke ; Peter Lütkes ; Melanie Fiedler ; Ernst Kreuzfelder ; Thomas Philipp ; Michael Roggendorf ; Hans Grosse-WildeELISpot assay as a sensitive tool to detect cellular immunity following influenza vaccination in kidney transplant recipients.
001569 (2006) J. A. Desheva [Russie] ; X. H. Lu [États-Unis] ; A. R. Rekstin [Russie] ; L. G. Rudenko [Russie] ; D. E. Swayne [États-Unis] ; N. J. Cox [États-Unis] ; J. M. Katz [États-Unis] ; A. I. Klimov [États-Unis]Characterization of an influenza A H5N2 reassortant as a candidate for live-attenuated and inactivated vaccines against highly pathogenic H5N1 viruses with pandemic potential
001578 (2005) Mark D. Wareing [Australie] ; Leonard C. Harrison ; Gregory A. TannockPulmonary CD4+ cytokine responses in mice reveal differences in the relative immunogenicity of cold-adapted influenza A vaccine donor strains.
001C00 (1996) H. Sagawa [Japon] ; A. Ohshima ; I. Kato ; Y. Okuno ; Y. IsegawaThe immunological activity of a deletion mutant of influenza virus haemagglutinin lacking the globular region.
002271 (1988) M. H. Snyder ; R. F. Betts ; D. Deborde ; E. L. Tierney ; M. L. Clements ; D. Herrington ; S. D. Sears ; R. Dolin ; H. F. Maassab ; B. R. MurphyFour viral genes independently contribute to attenuation of live influenza A/Ann Arbor/6/60 (H2N2) cold-adapted reassortant virus vaccines
002D90 (????) F I Polezhaev ; G N Budilovski ; L M Garmashova ; Iu R. Rome Ko-Gurko ; A Iu Egorov[Safety and high immunogenicity for children 3 to 15 of a mono- and a divaccine from recombinant influenza A/Brazil /11/78 (H1N1) and A/Bangkok/1/79 (H3N2) viruses obtained from a special donor attenuation base--the cold-adapted virus A/Leningrad/134/47/57 (H2N2)].
002D91 (????) I V Kiseleva ; N V Larionova ; L C P. Teley ; L G Rudenko[Restriction analysis of genome composition of live influenza vaccine].
002E00 (????) Iu Z. Gendon ; S G Markushin ; T M Tsfasman ; I I Akopova ; N K Akhmatova ; I B Koptiaeva[New cold-adapted donor strains for live influenza vaccine].
002E10 (????) S G Markushin ; Iu Z. Gendon ; G G Krivtsov ; I I Akopova ; A S Sukhno ; A D Pereverzev[Increase of immunogenicity of cold-adapted influenza vaccine by using adjuvant].
002E13 (????) M V Sergeeva ; V V Kuznetsov ; M A Kas'Ianenko ; A A Shaldzhian ; I A Repko ; M V Potapchuk ; Iu R. Romanova ; L M Tsybalova[Immunization with live attenuated A/H5N1 vaccine protects guinea pigs from reinfection].
002E39 (????) S G Markushin ; T M Tsfasman ; A V Terekhov ; K V Lisovskaya ; I I Akopova[COLD-ADAPTED A/KRASNODAR/101/35/59 (H2N2) STRAIN--A PROMISING STRAIN-DONOR OF ATTENUATION FOR PROCURATION OF LIVE INFLUENZA VACCINES].
000166 (2018) Tara M. Babu [États-Unis] ; Ranawaka A P M. Perera ; Joseph T. Wu ; Theresa Fitzgerald [États-Unis] ; Carolyn Nolan [États-Unis] ; Benjamin J. Cowling ; Scott Krauss [États-Unis] ; John J. Treanor [États-Unis] ; Malik PeirisPopulation Serologic Immunity to Human and Avian H2N2 Viruses in the United States and Hong Kong for Pandemic Risk Assessment
000212 (2018) Liudmila M. Tsybalova [Russie] ; Liudmila A. Stepanova [Russie] ; Marina A. Shuklina [Russie] ; Eugenia S. Mardanova [Russie] ; Roman Y. Kotlyarov [Russie] ; Marina V. Potapchuk [Russie] ; Sergei A. Petrov [Russie] ; Elena A. Blokhina [Russie] ; Nikolai V. Ravin [Russie]Combination of M2e peptide with stalk HA epitopes of influenza A virus enhances protective properties of recombinant vaccine.
000264 (2017) Nicholas Wohlgemuth [États-Unis] ; Yang Ye [États-Unis] ; Katherine J. Fenstermacher [États-Unis] ; Hsuan Liu [États-Unis] ; Andrew P. Lane [États-Unis] ; Andrew Pekosz [États-Unis]The M2 protein of live, attenuated influenza vaccine encodes a mutation that reduces replication in human nasal epithelial cells.
000283 (2017) Mizuho Suzuki ; Masatoshi Okamatsu ; Takahiro Hiono ; Keita Matsuno ; Yoshihiro SakodaPotency of an inactivated influenza vaccine prepared from A/duck/Hokkaido/162/2013 (H2N1) against a challenge with A/swine/Missouri/2124514/2006 (H2N3) in mice
000522 (2015) Yulia A. Desheva [Russie] ; Tatiana A. Smolonogina [Russie] ; Svetlana A. Donina [Russie] ; Larisa G. Rudenko [Russie]Serum strain-specific or cross-reactive neuraminidase inhibiting antibodies against pandemic А/California/07/2009(H1N1) influenza in healthy volunteers
000531 (2015) Milton Thomas [États-Unis] ; Zhao Wang [États-Unis] ; Chithra C. Sreenivasan [États-Unis] ; Ben M. Hause [États-Unis] ; Gourapura J Renukaradhya [États-Unis] ; Feng Li [États-Unis] ; David H. Francis [États-Unis] ; Radhey S. Kaushik [États-Unis] ; Mahesh Khatri [États-Unis]Poly I:C adjuvanted inactivated swine influenza vaccine induces heterologous protective immunity in pigs.
000533 (2015) Larisa Rudenko [Russie] ; Irina Isakova-SivakPandemic preparedness with live attenuated influenza vaccines based on A/Leningrad/134/17/57 master donor virus.
000556 (2015) Xiaolan Yang [République populaire de Chine] ; Jianyu Zhao [République populaire de Chine] ; Cheng Wang [République populaire de Chine] ; Yueqiang Duan [République populaire de Chine] ; Zhongpeng Zhao [République populaire de Chine] ; Rui Chen [République populaire de Chine] ; Liangyan Zhang [République populaire de Chine] ; Li Xing [République populaire de Chine] ; Chengcai Lai [République populaire de Chine] ; Shaogeng Zhang [République populaire de Chine] ; Xiliang Wang [République populaire de Chine] ; Penghui Yang [République populaire de Chine]Immunization with a live attenuated H7N9 influenza vaccine protects mice against lethal challenge.
000859 (2013) Matthew S. Miller [États-Unis] ; Thomas J. Gardner [États-Unis] ; Florian Krammer [États-Unis] ; Lauren C. Aguado [États-Unis] ; Domenico Tortorella [États-Unis] ; Christopher F. Basler [États-Unis] ; Peter Palese [États-Unis]Neutralizing antibodies against previously-encountered influenza virus strains increase over time: A longitudinal analysis
000A21 (2012) Juergen A. Richt [États-Unis] ; Barry Rockx [Canada] ; Wenjun Ma [États-Unis] ; Friederike Feldmann [Canada] ; David Safronetz [Canada] ; Andrea Marzi [Canada] ; Darwyn Kobasa [Canada] ; James E. Strong [Canada] ; Lisa Kercher [États-Unis] ; Dan Long [États-Unis] ; Don Gardner [États-Unis] ; Douglas Brining [États-Unis] ; Heinz Feldmann [Canada]Recently Emerged Swine Influenza A Virus (H2N3) Causes Severe Pneumonia in Cynomolgus Macaques
000A76 (2012) Alexandra S. Gambaryan [Russie] ; Natalia F. Lomakina ; Elizaveta Y. Boravleva ; Ekaterina A. Kropotkina ; Vadim V. Mashin ; Igor V. Krasilnikov ; Alexander I. Klimov ; Larisa G. RudenkoComparative safety, immunogenicity, and efficacy of several anti-H5N1 influenza experimental vaccines in a mouse and chicken models (Testing of killed and live H5 vaccine).
000B46 (2012) Jens C. Krause [États-Unis] ; Tshidi Tsibane [États-Unis] ; Terrence M. Tumpey [États-Unis] ; Chelsey J. Huffman [États-Unis] ; Randy Albrecht [États-Unis] ; David L. Blum [États-Unis] ; Irene Ramos [États-Unis] ; Ana Fernandez-Sesma [États-Unis] ; Kathryn M. Edwards [États-Unis] ; Adolfo Garcia-Sastre [États-Unis] ; Christopher F. Basler [États-Unis] ; James E. Jr Crowe [États-Unis]Human Monoclonal Antibodies to Pandemic 1957 H2N2 and Pandemic 1968 H3N2 Influenza Viruses
000B97 (2011) Guus F. Rimmelzwaan [Pays-Bas] ; Rogier Bodewes ; Albert D M E. OsterhausVaccination strategies to protect children against seasonal and pandemic influenza.
000C61 (2011) Joseph D. Comber [États-Unis] ; Tara M. Robinson ; Nicholas A. Siciliano ; Adam E. Snook ; Laurence C. EisenlohrFunctional macroautophagy induction by influenza A virus without a contribution to major histocompatibility complex class II-restricted presentation.
000C81 (2011) Kortney M. Gustin [États-Unis] ; Taronna R. Maines ; Jessica A. Belser ; Neal Van Hoeven ; Xuihua Lu ; Libo Dong ; Irina Isakova-Sivak ; Li-Mei Chen ; J Theo M. Voeten ; Jacco G M. Heldens ; Han Van Den Bosch ; Nancy J. Cox ; Terrence M. Tumpey ; Alexander I. Klimov ; Larisa Rudenko ; Ruben O. Donis ; Jacqueline M. KatzComparative immunogenicity and cross-clade protective efficacy of mammalian cell-grown inactivated and live attenuated H5N1 reassortant vaccines in ferrets.
000D08 (2011) Gary J. Nabel [États-Unis] ; Chih-Jen Wei [États-Unis] ; Julie E. Ledgerwood [États-Unis]Vaccinate for the next H2N2 pandemic now
000D63 (2011) Danuta M. Skowronski [Canada] ; Travis S. Hottes [Canada] ; Janet E. Mcelhaney [Canada] ; Naveed Z. Janjua [Canada] ; Suzana Sabaiduc [Canada] ; Tracy Chan [Canada] ; Beth Gentleman [Canada] ; Dale Purych [Canada] ; Jennifer Gardy [Canada] ; David M. Patrick [Canada] ; Robert C. Brunham [Canada] ; Gaston De Serres [Canada] ; Martin Petric [Canada]Immuno-epidemiologic Correlates of Pandemic H1N1 Surveillance Observations: Higher Antibody and Lower Cell-Mediated Immune Responses with Advanced Age
000D93 (2010) N A Mazurkova ; N N Ryndiuk ; L N Shishkina ; V A Ternovo ; Iu V. Tumanov ; L E Bulychev ; M O Skarnovich ; A S Kabanov ; S G Panchenko ; R P Ale Nikov ; T N Il'Ina ; V I Kuzubov ; S Ia Mel'Nikov ; A N Mironov ; S A Korovkin ; A N Sergeev ; I G Drozdov[Results of clinical trials on reactogenicity, safety, and immunogenicity of influenza allantoic intranasal live vaccine "Ultragrivac" (type A/H5N2)].
000E74 (2010) N. Ikonen [Finlande] ; M. Strengell ; L. Kinnunen ; P. Osterlund ; J. Pirhonen ; M. Broman ; I. Davidkin ; T. Ziegler ; I. JulkunenHigh frequency of cross-reacting antibodies against 2009 pandemic influenza A(H1N1) virus among the elderly in Finland.
000F91 (2010) Grace L. Chen [États-Unis] ; Elaine W. Lamirande [États-Unis] ; Chin-Fen Yang [États-Unis] ; HONG JIN [États-Unis] ; George Kemble [États-Unis] ; Kanta Subbarao [États-Unis]Evaluation of Replication and Cross-Reactive Antibody Responses of H2 Subtype Influenza Viruses in Mice and Ferrets
001062 (2009) Ilaria Capua [Italie] ; Anna Kajaste-Rudnitski [Italie] ; Elena Bertoli [Italie] ; Elisa Vicenzi [Italie]Pandemic Vaccine Preparedness—Have We Left Something Behind?
001225 (2008) Larisa Rudenko [Russie] ; Julia Desheva ; Sergey Korovkin ; Alexander Mironov ; Andrey Rekstin ; Elena Grigorieva ; Svetlana Donina ; Alexandra Gambaryan ; Anton KatlinskySafety and immunogenicity of live attenuated influenza reassortant H5 vaccine (phase I-II clinical trials).
001259 (2008) H. Li [République populaire de Chine] ; Y. Zhang ; Z H Ning ; X M Deng ; Z X Lian ; N. LiEffect of selection for phagocytosis in dwarf chickens on immune and reproductive characters.
001260 (2008) Xueli Hao [États-Unis] ; Taeg S. Kim ; Thomas J. BracialeDifferential response of respiratory dendritic cell subsets to influenza virus infection.
001739 (2003) G. A. Marsh [Australie] ; J. M. Watson [Australie] ; W. E. White [Australie] ; G. A. Tannock [Australie]An evaluation of the genetic stability and pathogenicity of the Russian cold-adapted influenza A donor strains A/Leningrad/134/17/57 and A/Leningrad/134/47/57 in ferrets
001790 (2002) W. E. P. Beyer [Pays-Bas] ; A. M. Palache [Pays-Bas] ; J. C. De Jong [Pays-Bas] ; A. D. M. E. Osterhaus [Pays-Bas]Cold-adapted live influenza vaccine versus inactivated vaccine: systemic vaccine reactions, local and systemic antibody response, and vaccine efficacy A meta-analysis
001B22 (1997) K. Hashigucci ; S. Tamura ; T. Kurata ; H. Kamiya ; T. Ishidate[Efficacy of nasal influenza vaccine combined with Escherichia coli heat-labile enterotoxin B subunit containing a trace amount of the holotoxin in healthy volunteers].
001D17 (1995) David Cotter [Irlande (pays)] ; Noriyoshi Takei [Royaume-Uni] ; Michael Farrell [Irlande (pays)] ; Pak Sham [Royaume-Uni] ; Peter Quinn [Royaume-Uni] ; Conall Larkin [Irlande (pays)] ; John Oxford [Irlande (pays)] ; Robin M. Murray [Royaume-Uni] ; Eadbhard O'Callaghan [Irlande (pays)]Does prenatal exposure to influenza in mice induce pyramidal cell disarray in the dorsal hippocampus?
001E35 (1994) Innocent N. Mbawuike [États-Unis] ; Susan B. Dillon [États-Unis] ; Sandra G. Demuth [États-Unis] ; Christopher S. Jones [États-Unis] ; Thomas R. Cate [États-Unis] ; Robert B. Couch [États-Unis]Influenza A subtype cross-protection after immunization of outbred mice with a purified chimeric NS1/HA2 influenza virus protein
002199 (1988) A. Müllbacher ; G L Ada ; R T HlaGamma-irradiated influenza A virus can prime for a cross-reactive and cross-protective immune response against influenza A viruses.
002348 (1986) G. I. Alexandrova [Russie] ; G. N. Budilovsky [Russie] ; T. A. Koval [Russie] ; F. I. Polezhaev [Russie] ; L. M. Garmashova [Russie] ; Yu. Z. Ghendon [Russie] ; Y. R. Romanova [Russie] ; A. A. Smorodintsev [Russie]Study of live recombinant cold-adapted influenza bivalent vaccine of type A for use in children: an epidemiological control trial
002567 (1983) M L Clements ; S. O'Donnell ; M M Levine ; R M Chanock ; B R MurphyDose response of A/Alaska/6/77 (H3N2) cold-adapted reassortant vaccine virus in adult volunteers: role of local antibody in resistance to infection with vaccine virus.
002754 (1981) H. Ertl [Australie] ; G. L. Ada [Australie]Roles of influenza virus infectivity and glycosylation of viral antigen for recognition of target cells by cytolytic T Lymphocytes
002881 (1979) B R Murphy ; H P Holley ; E J Berquist ; M M Levine ; S B Spring ; H F Maassab ; A P Kendal ; R M ChanockCold-adapted variants of influenza A virus: evaluation in adult seronegative volunteers of A/Scotland/840/74 and A/Victoria/3/75 cold-adapted recombinants derived from the cold-adapted A/Ann Arbor/6/60 strain.
002B01 (1976) J M GwaltneyThe use of live attenuated influenza vaccine ts-1(E) in man.
002D75 (????) T E Medvedeva ; Iu R. Romanova ; M I Gushchina ; L G Rudenko ; Iu Z. Gendon ; G I Aleksandrova ; A I Klimov[The ts phenotype of reisolates from children inoculated with live cold-adapted influenza vaccine type A].
002D88 (????) Iu A. Desheva ; T A Smolonogina ; M V Sergeeva ; A R Rekstin ; D. Swayne ; A I Klimov ; L G Rudenko[Study of biological properties of cold-adapted reassortant strain of influenza virus subtype H7N3].
002D97 (????) I V Kiseleva ; E A Bazhenova ; N V Larionova ; E A Fedorova ; I A Dubrovina ; I N Isakova-Sivak ; L G Rudenko[Peculiarity of reassortment of current wild type influenza viruses with master donor viruses for live influenza vaccine].
002E11 (????) L A Stepanova ; A A Kovaleva ; M V Potapchuk ; A V Korotkov ; V V Kupriianov ; E A Blokhina ; R Iu Kotliarov ; L M Tsybalova[Immunogenicity of recombinant proteins including ectodomain of M2 influenza virus A].
002E12 (????) A Iu Egorov ; L M Garmashova ; G N Nevedomskaia ; L I Bogomolova ; A M Kha Der ; G I Aleksandrova[Immunogenicity of attenuated reassortants of influenza A virus /Leningrad/134/47/57 (H2N2) for mice, depending on their genome].
002E26 (????) T A Smolonogina ; Iu A. Desheva ; A R Rekstin ; A N Mironov ; L G Rudenko[Evaluation of the anti-neuraminidase antibodies in clinical trials of the live influenza vaccine of the A(H5N2) subtype].
002E36 (????) L M Garmashova ; F I Polezhaev ; G I Aleksandrova[Cold-adapted strain of A/Leningrad/134/47/57 (H2N2)--a special attenuation donor of live influenza vaccine for children and the isolation of its recombinants].
002E48 (????) H F Maassab [États-Unis] ; M L BryantThe development of live attenuated cold-adapted influenza virus vaccine for humans.
002E58 (????) B R Murphy [États-Unis] ; E J Park ; P. Gottlieb ; K. SubbaraoAn influenza A live attenuated reassortant virus possessing three temperature-sensitive mutations in the PB2 polymerase gene rapidly loses temperature sensitivity following replication in hamsters.
000220 (2018) Guo Luo ; Aditya Ambati ; Ling Lin ; Mélodie Bonvalet ; Markku Partinen [Finlande] ; Xuhuai Ji ; Holden Terry Maecker ; Emmanuel Jean-Marie MignotAutoimmunity to hypocretin and molecular mimicry to flu in type 1 narcolepsy
000406 (2016) Wei Wang ; Esmeralda Alvarado-Facundo ; Qiong Chen ; Christine M. Anderson [États-Unis] ; Dorothy Scott [États-Unis] ; Russell Vassell ; Carol D. WeissSerum Samples From Middle-aged Adults Vaccinated Annually with Seasonal Influenza Vaccines Cross-neutralize Some Potential Pandemic Influenza Viruses.
000439 (2016) Svetlana Shcherbik [États-Unis] ; Nicholas Pearce [États-Unis] ; Irina Kiseleva [Russie] ; Natalie Larionova [Russie] ; Larisa Rudenko [Russie] ; Xiyan Xu [États-Unis] ; David E. Wentworth [États-Unis] ; Tatiana Bousse [États-Unis]Implementation of new approaches for generating conventional reassortants for live attenuated influenza vaccine based on Russian master donor viruses.
000497 (2015) E Y Boravleva ; I A Chvala ; N F Lomakina ; P I Repin ; N S Mudrak ; L G Rudenko ; A S Gambaryan ; V V Drygin[Testing of apathogenic influenza virus H5N3 as a poultry live vaccine].
000498 (2015) A V Lyapunov ; S I Kolesnikov ; M A Khasnatinov ; E L Manzarova ; I V Petrova ; V V Dolgikh ; G A Danchinova[Child and Adolescent Interepydemic Immunity to Influenza Viruses].

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 14 19:59:40 2020. Site generation: Thu Mar 25 15:38:26 2021